IMO - a major driver of lower C1 Costs is linked to the quarterly concentrate production. High utilisation and significant fixed cost nature seem to equate to GRR needing to produce more than 630k of concentrate /Q to deliver a quarterly C1 Cost under $80.00. Shutdown period is likely to reduce quarterly concentrate produced and lower number of production days for the quarter as Miningnut has previously stated.
Source: GRR Quarterly reports
Column 1 Column 2 Column 3 Column 4 Column 5 Column 6 Column 7 Column 8 Column 9 Column 10 Column 11 0 GRR Q1 2015 Q2 2015 Q3 2015 Q4 2015 Q1 2016 Q4 2016 Q1 2017 Q2 2017 Q3 2017 Q4 2017 1 Total BCM Mined 3,872,777 3,921,851 3,714,555 3,789,897 3,240,319 1,976,867 2,501,748 2,830,825 3,081,944 4,046,988 2 Concentrate Produced 709,646 588,186 637,927 670,474 664,257 604,608 497,800 181,499 583,822 696,483 3 Weight Recovery 47.8% 48.4% 48.4% 42.3% 40.8% 44.8% 44.8% 36.0% 53.2% 55.6% 4 C1 Costs $ 71.00 $ 88.00 $ 79.00 $ 73.00 $ 63.27 $ 80.13 $ 91.02 $ 252.44 $ 85.04 $ 76.89 5 Over 630kt Concentrate Yes No Yes Yes Yes No No No No Yes
- Forums
- ASX - By Stock
- GRR
- Quarterly predictions
Quarterly predictions, page-16
-
- There are more pages in this discussion • 113 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GRR (ASX) to my watchlist
(20min delay)
|
|||||
Last
23.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $266.1M |
Open | High | Low | Value | Volume |
23.5¢ | 24.0¢ | 23.5¢ | $54.29K | 228.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
15 | 515459 | 23.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
24.0¢ | 72746 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 219779 | 0.270 |
9 | 458580 | 0.265 |
26 | 932290 | 0.260 |
7 | 172530 | 0.255 |
22 | 717920 | 0.250 |
Price($) | Vol. | No. |
---|---|---|
0.275 | 405759 | 8 |
0.280 | 942702 | 17 |
0.285 | 372332 | 13 |
0.290 | 1710676 | 31 |
0.295 | 651900 | 8 |
Last trade - 12.40pm 25/11/2024 (20 minute delay) ? |
Featured News
GRR (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online